Clinical trial
Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058)
NCT00330395 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00330395 |
|---|---|
| Title | Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058) |
| Official title | A Multicenter, Sequential-Panel, Open-Label, Noncomparative Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Caspofungin Acetate in Neonates and Infants Less Than 3 Months of Age. |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Candidiasis |
| Intervention type | Drug |
| Interventions | caspofungin acetate |
| Enrollment | 16 |
| Start date | May 1, 2006 |
| Primary completion | Oct 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | May 26, 2006 |
| Last update posted | Feb 23, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: